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pcDNA-hNR1D1, pcDNA-hNR1D2, pcDNA-mlrh-1, and pcDNA-hLRH-1 were synthesized by Biowit Technologies (Shenzhen, China). The RevRE site mutated of Lrh-1/LRH-1 promoter construct were generated by polymerase chain reaction (PCR) amplification. The obtained fragments were cloned into the pGL4.11 plasmid (Promega, Madison, WI).
Synthesis and preparation of GSK2945
GSK2945 was synthesized as described previously (Trump et al., 2013) . The reductive amination of 4-chloro-2-methylbenzaldehyde (1) with 4-chlorobenzylamine (2) and sodium triacetoxyborohydride gave secondary amine 2 (3). A second reductive amination with 5-nitro-2-thiophenecarboxaldehyde (4) gave tertiary amine 3 (5), namely, the final product GSK2945. 4, 151.0, 139.2, 136.4, 134.5, 133.5, 133.1, 130.8, 130.5, 130.3, 128.8, 128.7, 126.2, 124.6, 58.1, 55.7, 53.0, 19.4 .
HRMS calcd for C20H19N2O2Cl2S (M+H)
+ requires m/z 421.054, found 421.045.
Pharmacokinetic studies
GSK2945 or SR8278 was formulated in 15% cremophor and administered to male C57BL/6 mice (22-24 g, n = 6 per each time point) at a dose of 10 mg/kg by intraperitoneal injection. At each time point, 3 mice were rendered unconscious with isoflurane for blood and liver (0.08, 0.17, 0.25, 0.5, 0.75, 1, 1.5, 2, 4, 6, 8, 10 and 12 h) sampling. The blood was collected by cardiac puncture. After washout of blood with ice-cold saline, the livers were rapidly removed, weighed, and stored at -80°C for further analysis.
The blood samples were centrifuged at 5,000 g (4°C ) for 10 min and the plasma was transferred into Eppendorf (EP) tubes. A 100-μl aliquot of plasma sample was subjected to the deproteinization using 500-μl acetonitrile (containing SR9011 as the internal standard). After 3-min vortex, the sample mixture was centrifuged at 13,000 g (4°C ) for 15 min. The resulting supernatant was collected and dried using Eppendorf
Concentrator Plus (Hamburg, Germany). The dry residuals were re-dissolved in 200-μl of acetonitrile/water (50:50, v/v). After centrifugation (13,000 g, 15 min), a 5-μl aliquot of the supernatant was injected into the UPLC-QTOF/MS system (Waters, Milford, MA).
The livers were homogenized at a ratio of 1/2 (w/v) in saline solution. 0.2-ml of liver homogenate was mixed with 1-ml acetonitrile containing the internal standard SR9011.
The mixture was vortexed for 3 min and subsequently subjected to 13,000 g centrifugation at 4°C for 15 min. The supernatant was collected and dried using Eppendorf Concentrator Plus (Hamburg, Germany). The dry residues were redissolved in 200-μl acetonitrile/water (50:50, v/v). After centrifugation (13,000 g, 15 min), the supernatant was subjected to UPLC-QTOF/MS analyses.
Drug quantification by UPLC-QTOF/MS
Concentrations of GSK2945 in plasma and liver samples were determined using a UPLC-QTOF/MS system consisting of Waters ACQUITY UPLC and Xevo G2 QTOF/MS (Liu et al., 2014) . Chromatographic separation was performed on a BEH column (2.1  50 mm, 1.7 m; Waters). A gradient elution was applied using formic sampling cone, and extraction cone voltages were 3000, 20 and 4 V, respectively. The desolvation gas (nitrogen), and cone gas were set to 800 and 30 l/h, respectively. The desolvation and source temperature were 400°C , and 120°C , respectively. An external reference (lockspray) of 2 ng/ml leucine encephalin (m/z 556.2771) was infused at a rate of 2 l/min to ensure the mass accuracy throughout an entire run. Supplementary Figure S2 . Pharmacokinetic analyses of GSK2945 or SR8278 in mice (n = 6 per time point). a, plasma concentrations versus time profiles. b distribution of GSK26945 and SR8278 in mouse liver. c, pharmacokinetic parameters derived from fitting the plasma data with a two-compartment model. Figure S4 . Liver function tests of vehicle-versus GSK2945-treated mice. ALT, alanine transaminase; AST, aspartate aminotransferase; AKP, alkaline phosphatase. C57BL/6 mice were administered repeated doses of GSK2945 (10 mg/kg, i.p.) twice daily at ZT0 and ZT12 for 7 days. On day 8 (ZT12), groups of animals (n = 5) were sacrificed to collect blood. Plasma ALT, AST and AKP were determined by ALT kit, AST kit, and AKP kit (Jiancheng Bioengineering Institute, Nanjing, China), respectively. Supplementary Figure S6 . Rev-erbα regulation of cholesterol-related genes in the liver. C57BL/6 mice were administered repeated doses of GSK2945 (10 mg/kg, i.p.) twice daily at ZT0 and ZT12 for 7 days and groups of mice (n = 5) were sacrificed and gene expression was assessed by qPCR. *P < 0.05 versus vehicle control. Data are presented as mean  SEM (n = 5). small intestine, and feces after vehicle-and GSK2945-treated mice by UPLC-QTOF/MS analyses. Data are presented as mean ± SEM (n = 5). # p < 0.05 Western diet versus normal diet; *p < 0.05 vehicle-treated versus GSK2945-treated hypercholesterolemic mice. CA, cholic acid; CDCA, chenodeoxycholic acid; DCA, deoxycholic acid; β-MCA, β-muricholic acid; T, tauro-conjugated species.
